-
REBALANCING RESOURCES ALLOCATED TO MEDICINES: HOW MUCH IS ENOUGH?
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN AMONG LUPUS NEPHRITIS PATIENTS WITH END-STAGE RENAL DISEASE: A REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
TARGETED THERAPY, IMMUNOTHERAPY, AND MOLECULAR TESTING IN ADVANCED SOLID TUMORS: A 2021-2025 MEDICARE ANALYSIS
Mar 18, 2026, 21:38 PM -
EVALUATING INDIVIDUAL-LEVEL ASSOCIATION BETWEEN RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (MHSPC): AN INDIRECT ILLNESS-DEATH MODELING APPROACH
Mar 18, 2026, 21:38 PM -
MARKOV MODEL-BASED COST-UTILITY ANALYSIS COMPARING RANIBIZUMAB WITH PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY IN INDIA
Mar 18, 2026, 21:38 PM -
A REAL-WORLD RETROSPECTIVE COHORT STUDY CHARACTERIZING TREATMENT PATTERNS AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
NEW FAILURE MODES, OLD STANDARDS: WHY ARTIFICIAL INTELLIGENCE (AI) DEMANDS DIFFERENT VALIDATION APPROACHES IN EVIDENCE SYNTHESIS
Mar 18, 2026, 21:38 PM -
ENSURING ESTIMAND AND POPULATION CONSISTENCY ACROSS HEALTH TECHNOLOGY ASSESSMENT DOSSIER COMPONENTS
Mar 18, 2026, 21:38 PM -
A MACHINE LEARNING APPROACH FOR EARLY DETECTION OF POLYCYSTIC OVARY SYNDROME (PCOS): ENHANCING DIAGNOSTIC EFFICIENCY USING EXTRA GRADIENT BOOST (XGBOOST)
Mar 18, 2026, 21:38 PM -
CAREGIVER IMPACT VALUE FRAMEWORK: UNLOCKING SOCIETAL VALUE
Mar 18, 2026, 21:38 PM -
YEARLY TREND OF OBESITY PREVALENCE AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES: 2021-2025
Mar 18, 2026, 21:38 PM -
COMPREHENSIVE REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) OUTPERFORM CUSTOM REVIEWS FOR STRATEGIC HEALTH TECHNOLOGY ASSESSMENT (HTA) AND MARKET ACCESS (MA) PLANNING: AN ADVANCED METASTATIC BREAST CANCER (MBC) EXAMPLE
Mar 18, 2026, 21:38 PM -
ESTABLISHING VALIDITY AND DEVELOPING A PREDICTOR TOOL FOR ESTIMATION OF WILLINGNESS TO PAY BASED THRESHOLD FOR INDIA
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC EVALUATION OF A NOVEL PATIENT-PROVIDER TOOL FOR ASSESSING DIABETES SELF-MANAGEMENT KNOWLEDGE AND BEHAVIOR IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
VALIDATION OF AN AGENTIC LARGE LANGUAGE MODEL (LLM) SYSTEM IN THE REVIEW STAGE OF A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR): A SOLUTION TO INSTANT AND EASY ACCESS TO CLINICAL TRIAL DATA (CTD)
Mar 18, 2026, 21:38 PM -
PEMBROLIZUMAB ALONE VERSUS CHEMO-IMMUNOTHERAPY IN METASTATIC NSCLC: A 2024 MEDICARE-BASED MARKOV COST-EFFECTIVENESS ANALYSIS
Mar 18, 2026, 21:38 PM -
SOURCES OF HOSPITAL ADMISSION COSTS IN HTA SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Mar 18, 2026, 21:38 PM -
MECHANICAL VENTILATION IS UNDER REPORTED ON CLAIMS: A COMPARISON OF CHARGE DESCRIPTION MASTER DATA TO CLAIMS DATA
Mar 18, 2026, 21:38 PM -
DEFINING CURATIVE POTENTIAL IN EARLY-STAGE MELANOMA: WHERE PHYSICIANS AND PAYERS ALIGN AND WHERE THEY DON’T
Mar 18, 2026, 21:38 PM
